BNP Paribas Financial Markets’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$173K Sell
55,951
-127,297
-69% -$393K ﹤0.01% 3022
2025
Q1
$640K Sell
183,248
-64,748
-26% -$226K ﹤0.01% 2259
2024
Q4
$811K Sell
247,996
-58,371
-19% -$191K ﹤0.01% 2194
2024
Q3
$1.18M Sell
306,367
-41,868
-12% -$161K ﹤0.01% 1729
2024
Q2
$1.08M Sell
348,235
-1,200
-0.3% -$3.71K ﹤0.01% 1623
2024
Q1
$902K Buy
349,435
+57,390
+20% +$148K ﹤0.01% 1946
2023
Q4
$730K Buy
292,045
+49,745
+21% +$124K ﹤0.01% 1927
2023
Q3
$492K Buy
242,300
+71,526
+42% +$145K ﹤0.01% 2097
2023
Q2
$393K Buy
170,774
+85,170
+99% +$196K ﹤0.01% 2115
2023
Q1
$259K Buy
85,604
+65,539
+327% +$199K ﹤0.01% 2430
2022
Q4
$46.8K Sell
20,065
-18,603
-48% -$43.3K ﹤0.01% 2776
2022
Q3
$73.9K Buy
38,668
+14,832
+62% +$28.3K ﹤0.01% 3172
2022
Q2
$64.6K Buy
23,836
+16,093
+208% +$43.6K ﹤0.01% 2854
2022
Q1
$23.1K Sell
7,743
-17,113
-69% -$51K ﹤0.01% 3132
2021
Q4
$96.7K Buy
24,856
+9,101
+58% +$35.4K ﹤0.01% 2966
2021
Q3
$67.6K Buy
15,755
+9,318
+145% +$40K ﹤0.01% 2835
2021
Q2
$19.5K Buy
+6,437
New +$19.5K ﹤0.01% 2946
2020
Q3
Sell
-6
Closed -$11 3577
2020
Q2
$11 Sell
6
-64
-91% -$117 ﹤0.01% 3642
2020
Q1
$71 Hold
70
﹤0.01% 3609
2019
Q4
$195 Sell
70
-3,892
-98% -$10.8K ﹤0.01% 3640
2019
Q3
$6.04K Hold
3,962
﹤0.01% 3598
2019
Q2
$8.24K Sell
3,962
-3,385
-46% -$7.04K ﹤0.01% 3518
2019
Q1
$26.3K Buy
+7,347
New +$26.3K ﹤0.01% 3229
2018
Q4
Sell
-1,155
Closed -$10.9K 3646
2018
Q3
$10.9K Hold
1,155
﹤0.01% 3018
2018
Q2
$8.43K Buy
+1,155
New +$8.43K ﹤0.01% 3208